Lv1
40 积分 2024-02-07 加入
Influence of Immunogenicity on the Long-Term Efficacy of Infliximab in Crohn's Disease
10天前
已完结
Report of the ECCO pathogenesis workshop on anti-TNF therapy failures in inflammatory bowel diseases: Definitions, frequency and pharmacological aspects
1个月前
已完结
Pharmacokinetics of Adalimumab in Inflammatory Bowel Diseases
1个月前
已关闭
Immunogenicity of Therapeutic Antibodies Used for Inflammatory Bowel Disease: Treatment and Clinical Considerations
1个月前
已完结
Microbial phosphoketolase promotes histone lactylation to improve anti-TNF therapy efficacy in inflammatory bowel disease
1个月前
已完结
Appendicectomy versus switching to a JAK inhibitor in inducing remission in patients with active ulcerative colitis after biologic therapy failure (COSTA): 1-year results of a multicentre, prospective, cohort study
3个月前
已完结
Human genetics guides the discovery of CARD9 inhibitors with anti-inflammatory activity
4个月前
已完结
Intensified versus standard dose infliximab induction therapy for steroid-refractory acute severe ulcerative colitis (PREDICT-UC): an open-label, multicentre, randomised controlled trial
5个月前
已完结
Anti-TNF-associated immunogenicity: use a retroactive drug but a proactive approach
5个月前
已关闭
Assessment of the influence of Fc‐γ receptor polymorphisms on biologics' pharmacokinetics in Tunisian rheumatoid arthritis patients
6个月前
已完结
皖公网安备34019202002308
